INTRODUCTION
The subject of pregnancy and diabetes can be considered from two main points of view: that of the baby and that of the mother.
There is no doubt that the children born to diabetic mothers (both before and after the development of clinical diabetes) commonly exceed the mean body weight for their gestational age, have a characteristic appearance, and have a high perinatal mortality, 10\p=n-\20% even when conditions are optimal for delivery (Farquhar, 1959; Gellis & Hsia, 1959; Pedersen & Pedersen, 1967) . However, as Farquhar (1965a) has pointed out, facts about the metabolic and hormonal changes in the infant of the diabetic mother are hard to establish since such babies are relatively uncommon, the demands of research and good clinical practice frequently conflict, and the greater proportion of deaths occur in utero. Moreover, the investigator in this field has particular problems in obtaining data from comparable normal infants against which his findings in infants of diabetic mothers can be evaluated. The energy meta¬ bolism and hormonal status of the normal newborn is unique and peculiar and in the immediate postnatal period, rapidly changing. Timing is of vital importance and serial observations are essential to obtain meaningful results. Quite apart from the ethical problems involved in obtaining normal controls, there are difficulties relating to the standardization of conditions at delivery which can affect the metabolic status of the infant at birth (these include the state of hydration and nutrition of the mother, and the mode of delivery (Cornblath, Wybregt & Baens, 1961) , and the problem of whether the control group should be matched for maturity by the use of gestational age or birth weight. So many studies have lacked adequate controls and/ or have failed to standardize the experimental situation that it is not surprising that different investigators have so often provided seemingly contradictory results, and that the established facts are few.
Recent research has shed some light on the morphology of the foetus in diabetic pregnancy, but has done little to explain the high perinatal mortality ; it has become evident that these two features are not intimately linked (Farquhar, 1962) . It is still not possible to identify the individual pregnancy at risk with any degree of accuracy, or to say with certainty that the increased foetal mortality associated with gesta¬ tional diabetes can be reduced by current treatment (O'Sullivan, Gellis, Dandron & Tenney, 1966 
a).
As far as the mother is concerned, it is generally agreed that pregnancy frequently worsens carbohydrate tolerance in mild stable diabetics who are being maintained by diet alone, that it increases the insulin requirement of insulin-dependent diabetics and even produces a state of temporary diabetes in previously normal women who may return to apparent normality after delivery (Jackson, 1961 a). On these grounds it has become usual to state that pregnancy is diabetogenic. These considerations, however, indicate a diabetogenic effect only in patients with established, or proven latent, diabetes and do not necessarily indicate that pregnancy is diabetogenic in potential diabetics or normal subjects, or that repeated childbearing, as Pyke (1956) has suggested, is a factor of importance in leading to the development of clinical diabetes in those genetically susceptible. Recent studies of the changes which occur in carbo¬ hydrate metabolism and insulin secretion in normal pregnancy suggest that pregnancy probably represents a functional burden on the beta cells of the pancreas. However, the results of epidemiological studies indicate that it is unlikely that repeated childbearing can completely explain the well-documented preponderance of women with diabetes in the population (Jackson, 1967) although it is probably a contributory factor.
These aspects of pregnancy and diabetes will be examined in this review. The de¬ tailed clinical management of pregnancy in the diabetic mother will not be considered, except in so far as it impinges on the subject under discussion. Recent reviews cover¬ ing this subject are by Kyle (1963) and Jackson (1967) .
EFFECT ON THE FOETUS OF DIABETIC DIATHESIS IN THE MOTHER

Size
It used to be thought that the excessive size of many infants born to diabetic women was due to water retention since they look oedematous, their limbs can sometimes be made to pit on pressure, they tend to pass more urine, and were thought to lose more absolute weight in the first few days of life than did babies in the normal weight range. However, when they were compared directly with infants who were similarly fed and who had been born by the same route to normal women, and the weight loss was related to the initial birth-weight, no significant difference in the amount of weight lost could be demonstrated between the two groups (Farquhar & Sklaroff, 1958) .
The careful studies of Osier (1960a, b, c, d ) confirmed independently by other investigators (Cheek, Maddison, Malinek & Coldbeck, 1961; Clapp, Butterfield & O'Brien, 1962; Cokingitin, Hanna & Jackson, 1963) , showed that as a group the infants of diabetic women have less extracellular water and less total body water than normal infants. Osier (1960a, b, c, d ) interpreted these findings as being con¬ sistent with an increased amount of body fat. Subsequently, by direct measurement of the subcutaneous fat both by skinfold thickness and by X-ray, he was able to show that these infants are fat to an extent corresponding to their size. Direct analysis of cadavers has confirmed this conclusion (Fee & Weil, 1963) .
Visceromegaly contributes also to the excessive weight; but the weights of the organs are proportional to the size of the babies and are no greater than those of normal infants of the same weight (Jackson, 1967) . Apart from their fat content there is little evidence that the bodies of babies of diabetic mothers differ from normal infants to any marked extent as far as other tissues are concerned. However, Osier (1960 a) , attempting to explain the relatively high intracellular water which he found associated with the reduction in total body water, and the fact that infants of diabetic mothers pass rather more urine than normal in the first few days of life, has suggested that an increased deposition of glycogen may occur.
The babies are long as well as heavy (Farquhar, 1959) . In spite of this, develop¬ ment of ossification centres corresponds to gestational age rather than to size (Cardell, 19536; Osier & Pedersen, 1960) .
Energy metabolism and hormonal status Normal newborn infant
It is currently accepted that nervous system activity in utero is minimal (Barcroft, 1938) , that the foetus obtains its energy from carbohydrates, and that foetal tissues are organized for the exclusive use of carbohydrate as an energy source. Fat catabolism does not seem to occur prenatally : on the contrary, towards the end of gesta¬ tion fat is laid down (Popjak, 1954) . Thus immediately after birth the respiratory quotient is about 1-0 (Cross, Tizard & Trythall, 1957) , and low levels of free fatty acids are found in the umbilical blood both of full-term infants born normally (Van Duyne <fe Havel, 1959) , and of foetuses delivered by Caesarean section (Novak, At Shelley, 1964; Shelley & Neligan, 1966) for use by glucose-dependent tissues such as erythrocytes and brain.
The potential of various adult organs to derive energy from long-chain fatty-acid oxidation is, to some extent at least, dependent on previous diet. The metabolic pattern of animals fed a high fat diet is altered in that their tissues obtain a much greater proportion of energy from lipid metabolism than control animals fed an isocaloric diet high in carbohydrate (Samuels, Gilmore & Reinecke, 1948 In the adult, glucose, free fatty acids, insulin and growth hormone interact in the regulation of energy metabolism with adrenaline, the glucocorticoids, glucagon and thyroxine playing subsidiary but important roles (Unger, 1966 (Cornblath & Schwartz, 1966) . It has been suggested that although glycogen stores in the liver are adequate at birth there may be inadequate hormonal control of glycogenolysis Schwartz, Adam, Chen & McCann, 1966) . In any case the amount of glycogen in the liver could not maintain the blood glucose level for longer than a few hours (Shelley, 1961) so that the baby has to live on fat and rely on gluconeogenesis for his source of glucose for the brain until he is fed. Little is known about the efficiency of gluconeogenesis in the newborn human infant, although it seems that it may be poor (Greenberg & Hahn, 1966) . Although it seems that in the first few days of life the metabolism of the infant can maintain itself at a lower level of blood sugar than in child or adult, there is sometimes difficulty in maintaining even the low level and ' jitteriness' or actual fits occur. Fits will force the muscles to give up some of their carbohydrate stores in the form of lactic acid which can be utilized by the brain. It seems likely that the brain of the newborn is able to use other sub¬ strates to some extent at least, but it is still probably true that it utilizes glucose pri-marily, and that its hormonal responses are aimed at sparing glucose for the brain.
As far as the brain is concerned anything which reduces the peripheral utilization of glucose will indirectly provide more glucose for the brain. The metabolism of the normal newborn baby is characterized by poor peripheral utilization of glucose (Baird & Farquhar, 1962; Schwartz, Bowie & Mulligan, 1962; Bowie, Mulligan & Schwartz, 1963; Cornblath, Wybregt & Baens, 1963; von Euler, Larsson & Persson, 1964) . This is associated with low plasma insulin levels (Baird & Farquhar, 1962; Milner, & Wright, 1966; Jorgensen, Deckert, Pedersen <fe Pedersen, 1966; Spellacy, Carlson & Birk, 1967) and can be corrected by giving insulin (Cornblath et al. 1963) , or repeated administration of glucose (Bowie et al. 1963 ). Slone and his colleagues (1966) have shown that the adult pattern is present by 4 weeks of age.
It has been shown (Cross et al. 1957 ) that the respiratory quotient (RQ) of the normal newborn infant begins to fall from 1-0 at birth to 0-7 by the third day of life. Although such data must be interpreted cautiously, a fall of this magnitude is usually acceptable evidence of a change from the utilization of carbohydrate to the utilization of fat as a source of calories. Kaye & Kumagai (1958) were first to present evidence of mobilization of fat reserves soon after birth and it is now well established that the levels of free fatty acids and glycerol rise steeply within the first few hours after delivery, reach a maximum level within 24 hr. after birth and fall off slowly thereafter, although at 1 yr. of age the free fatty-acid level is still higher than that in adults (Van Duyne & Havel, 1959; Novak, Melichar, Hahn & Koldovsky, 1961; Novak, Melichar & Hahn, 1965 a; Novak, Melichar, Hahn & Koldovsky, 19656; Van Duyne, 1966; Keele, Kay, Brown <fe Nordquist, 1966; Melichar, Novak, Zoula, Hahn & Koldovsky, 1966; Persson & Gentz, 1966; Melichar & Wolf, 1967; Milner & Wright, 1967 (Keele et al. 1966 ). The effect of administering glucose seems to depend on the time at which it is given. If hyperglycaemia is produced in the infant at birth by giving the mother an intravenous infusion of glucose during delivery there is either a smaller than normal fall in free fatty acids in the foetus (Melichar, Novak, Sabata, Hahn <fe Koldovsky, 1965; Melichar et al. 1966; Roux <fe Romney 1967) or an actual rise (Sabata, 1966) . Similarly in experi¬ ments in vitro, addition of glucose to the incubation medium fails to inhibit the release of free fatty acids from adipose tissue obtained from newborn infants up to 15 hr. after birth ). Administration of glucose after birth, however, reduces the plasma free-fatty-acid level in vivo, and in vitro the release of free fatty acids from adipose tissue obtained from these infants is inhibited by the addition of glucose to the incubation medium (Novak et al. 1961; Novak et al. 1966 ).
In fasting infants the level of ketone bodies in the blood is increased after the twelfth post-natal hour and remains elevated until the fourth post-natal day, by which time there is usually a significant intake of calories (Persson & Gentz, 1966; Melichar, Drahota & Hahn, 1967 (Cornblath, Segal & Smith, 1967 (Cornblath et al. 1965; Milner <fe Wright, 1966 (Van Duyne, 1966) . This would correlate well with other signs of stimulation of the sympathetic system, e.g. tachycardia, increase in blood pressure, etc., in the first 30 min. of life (Desmond, Franklin, Valvona, Hill, Plumb, Arnold & Watts, 1963) . Foetuses delivered by Caesarean section show a similar post-natal increase in free fatty acids to those delivered vaginally, i.e. the sympathetic system of the newborn is triggered by the transition from the intra-to the extra-uterine environment and not by the stress of labour and delivery. The critical triggering factor could be a fall in temperature (Schiff, Stern & Leduc, 1966; Persson & Gentz, 1966) . The decrease in plasma glucose concentration could also be a factor as in the adult (Kaye, Davidson, Williams, Kumagai & Picon, 1961) . When expressed in terms of body weight, the amount of adrenaline and noradrenaline excreted by the newborn infant is comparable to that in the adult (Greenberg & Gardner, 1960) and, like the adult, the newborn secretes increased amounts of adrenaline in response to a fall in blood sugar (Greenberg, Lind & von Euler, 1960) . Increased levels of plasma catecholamines are found in placental insufficiency, and in newborn infants with the respiratory distress syndrome, who have usually lower blood glucose levels than normal infants (Cheek, Malinek & Fraillon, 1963) . Apart from their effect on lipolysis, catecholamines would also inhibit the secretion of insulin (Porte, Grober, Kuzuya & Williams, 1966) and so contribute to glucose sparing.
The full lipolytic effect of both growth hormone and adrenaline is not achieved in the absence of the adrenal cortex (Fain, 1962) . It has been shown that cortisol is the major circulating free 17-hydroxycorticosteroid in the normal newborn infant as in the adult (Migeon, 1959; Ulstrom, Colle, Burley & Gunville, 1960a, b (Aarskog, 1963 (Aarskog, , 1965 Kenny, Precyasombat, Migeon, Laurence & Richards, 1966) (Kenny et al. 1966) . This difference between the data on cortisol production and urinary excretion is accounted for by the unique pattern of cortisol metabolism in the immediate post-natal period (Migeon, 1959; Ulstrom et al. 1960 a, b; Reynolds Colle & Ulstrom, 1962; Reynolds, 1963; Kenny, Malvaux & Migeon, 1963; Cathro, Birchall, Mitchell & Forsyth, 1965) . Thyroid hormone is also a powerful fat-mobilizing agent (Rich, Bierman & Schwartz, 1959) . A rise of serum protein-bound iodine in the newborn up to 40 hr. after birth was first reported by Danowski and his colleagues (1951) and has since been shown to be related to greatly increased activity of the thyroid gland as indi¬ cated by increased saturation of thyroxine-binding proteins and the very high uptake of labelled iodine (van Middlesworth, 1954; Fisher, Oddie & Burroughs, 1962; Marks & Man, 1965; Perry, Hodgman & Starr, 1965 (Pedersen, 1952; Komrower, 1954 Pedersen (1952) there is a negative correlation between birth-weight and blood-glucose level, and McCann and his colleagues (19666) have reported that the degree of hypoglycaemia is related to the degree of impaired carbohydrate tolerance shown by the mother. Infants of diabetic women have also been shown to dispose of a glucose load in the blood much more quickly than normal newborn infants, and this is true for infants of both women with insulin-dependent (Baird & Farquhar, 1962) and untreated gestational diabetes (Gentz, Lunell, Persson & Sterky, 1967) . However, infants of women with mild diabetes treated with diet alone or with an oral hypoglycaemic agent may not show this phenomenon (Isles, Dickson & Farquhar, 1968 ). Failure to demonstrate a difference between normal infants and infants of insulin-dependent diabetic mothers with respect to glucose tolerance Pedersen, Pederson & Jorgensen, 1966) can pro-bably be accounted for by the method used to estimate the blood glucose concentra¬ tion. In the newborn infant the determination of the concentration of glucose in whole blood is peculiarly difficult ; the glucose levels are lower, and the haematocrit and the concentration of interfering substances (glutathione, uric acid, bilirubin) higher, than in adults. Moreover, the effect of the non-glucose reducing substances will increase as the blood glucose concentration falls and will vary as the haemato¬ crit varies (dependent on such factors as time of clamping of the cord and age), since the erythrocytes contain about five times as much of the non-glucose reducing sub¬ stances as plasma. This problem has recently been systematically investigated by Hjelm & Sjölin (1965) and by Ek & Daae (1967) . Their results show that the otoluidine (Hyvärinen <fe Nikkilä, 1962) and glucose-oxidase (Hjelm & de Verdier, 1963) Opinion is divided whether low blood glucose levels in the newborn infant of the diabetic mother cause symptoms leading to future disability and even death. Pedersen (1952) , Komrower (1954) and are of the opinion that babies of both diabetic and normal women can show no abnormal symp¬ toms and suffer no permanent damage at blood glucose levels below 20 or even 10 mg./100 ml. Other authors are much more concerned about the immediate and long-term effects of hypoglycaemia in these infants. There can be little doubt that neonatal hypoglycaemia causes, in some cases, cerebral damage in the infants of non-diabetic women (Cornblath, Odell & Levin, 1959; Brown & Wallis, 1963; Neligan, Robson & Watson, 1963; Anderson, Milner & Strich, 1966) and it seems unlikely that the central nervous system of the infant of the diabetic woman is uniquely protected from the deleterious effects of prolonged and severe hypoglycaemia. On the other hand, on reviewing the literature there is very little evidence that hypo¬ glycaemia is responsible for a significant proportion of the deaths in this group of babies. Since specific enzymic methods for estimating glucose have become wide¬ spread it is now clear that low blood glucose values are very common in newborn babies, and that in the vast majority there are no symptoms and apparently no long-term sequelae. There is a need for investigations of the use of other metabolic substrates by the brain of the newborn infant and for long-term studies specifically designed to define accurately the effect of hypoglycaemia on the mortality, morbidity and ultimate mental development of babies with low blood glucose levels in the neonatal period. Until such information is available it has been suggested that infants particularly prone to hypoglycaemia, for instance, infants of diabetic mothersshould receive prophylactic therapy. The administration of sugars, such as fructose, which do not stimulate the secretion of insulin (Grodsky, Batts & Bennett, 1963) may be a good method of treating them (McCann, Adam, Likly & Schwartz, 1966a) .
The glucose tolerance of normal newborn infants can be made to conform to that of the newborn infants of diabetic women and of normal adults by the administration of insulin (Farquhar, 19656) , and babies of diabetic mothers can break down glycogen when given an injection of glucagon (Cornblath, Nicolopoulos, Ganzon, Levin, Gordon & Gordon, 1961) .
The immediate postnatal metabolism of the infant of the diabetic mother is characterized by lower than normal plasma ketone bodies ) and non-esterified fatty acid levels as well as by hypoglycaemia (Melichar, Novak, Hahn & Koldovsky, 1964; Chen, Adam, Laskowski, McCann & Schwartz, 1965; Joassin, Parker, Pildes & Cornblath, 1967) . According to van Duyne (1966) : 'If it is assumed that early release of free fatty acids and rapid utilization by non-glucose dependent tissues is a biochemical response designed to satisfy increased neonatal energy needs as well as to conserve glycogen stores for use by glucose-dependent systems, then it follows that inadequacies in this response could contribute to altera¬ tions in perinatal physiology detrimental to survival. ' Van Duyne also suggests that factors affecting the release of non-esterified fatty acids be given the same attention as those influencing the newborn's respiratory, cardiovascular and nervous system, or acid-base balance immediately after birth. The difficulties of the infant of the diabetic mother in maintaining metabolic homeostasis in the immediate neonatal period are similar to those observed in carbohydrate-fed adult animals subjected to sudden caloric deprivation, and the hormonal status of these infants is significantly different from the normal newborn infant.
Hyperinsulinism. Perhaps the most common and characteristic morphological change found in infants born to diabetic mothers post mortem is hypertrophy of the pancreatic islets due mainly to hyperplasia of the beta cells (Cardell, 1953 (Steinke & Driscoll, 1965) . From their histological appear¬ ances these beta cells seem to have been functionally active, but as Ogilvie (1944) and Santos, McCance & Rändle (1955) have pointed out, it cannot be assumed that beta-cell hyperplasia necessarily indicates that abnormally large amounts of insulin were synthesized and released into the peripheral circulation. However, direct evi¬ dence in favour of increased insulin secretion by infants of diabetic mothers has been provided by Baird & Farquhar (1962) The immunoassay of insulin in the blood of infants born to diabetic mothers treated with insulin is complicated by the presence of antibodies to insulin which cross the placenta from the maternal circulation (Spellacy & Goetz, 1963a ; Klink & Estrich, 1964; It seems more reasonable to suppose that the characteristic hyperinsulinism shown by the infant of the insulin-treated diabetic mother immediately after birth is the result of abnormal stimulation of the foetal pancreas in utero by another factor (or factors) transmitted across the placenta from the mother, and that it is the baby's own insulin which is responsible for the increased deposition of body fat. However, it should be noted that although the beta cells of the human foetus appear to be functionally active from an early stage (Robb, 1961) (Wilkerson & Remein, 1957; Wilkerson, 1959; O'Sullivan et al. 1966a) ; by clinical experience in the management of pregnancy in the insulin-dependent diabetic which has shown that rigid control of the maternal blood-sugar level lowers not only the foetal mortality but also foetal birth weight (Pedersen, 1952; Pedersen & Brandstrup, 1956; Oakley, 1961) ; by experiments showing a rise in foetal plasma insulin concentration after infusion of glucose to women in labour (Milner & Hales, 1965) ; and lastly by the increase in foetal birth weight associated with experimental diabetes in animals (Harding, Kinch & Stevenson, 1962) .
Moreover, the infant of a normal mother is able to deal more readily with a glucose load after previous stimulation with glucose (Bowie et al. 1963) (Hagbard, 1958; Hagen, 1961; Lunell, 1966; Kalkhoff, Richardson & Stoddard, 1968) , not all cases can be explained on this basis, and other metabolic, constitutional and probably inherited factors are almost certainly involved in the production of the big baby.
It has been suggested that the primary event in the development of diabetes in man might be an abnormality of glyceride metabolism, and that abnormalities of glucose metabolism might be secondary (Rändle, Garland, Hales & Newsholme, 1963; Hales <fe Rändle, 19636) . In the light of this suggestion the study of Mueller, Solomon & Brown (1964) is of interest. These workers found that the maintenance of a high concentration of free fatty acid in the plasma of pregnant rats led to an abnormal accumulation of fat in the foetus. However, there seems to be no significant dif¬ ference between normal and diabetic pregnancy in respect of maternal free fatty acids (Burt, 19606) ; Fairweather (1965) , Quinto, Bottiglioni & Flamigni (1967a, 6) and Koren & Shafrir (1964) Jackson's (1954) suggestion that the children of diabetic men are unusually heavy, but among male subjects the percentage not knowing the weights of their children at birth was so high that we felt that the information was unreliable. Farquhar (1962) has drawn attention to the fact that while it is probably true that in the diabetic group as a whole the average birth weight increases as the time for the development of clinical diabetes approaches (Miller, 1945; Paton, 1948; Kriss & Futcher, 1948) , there is a wide variation in patterns of family birth weight in prediabetic and diabetic pregnancy. He has shown that while some women bear infants of steadily increasing weight, others are remarkably consistent over many years, while in some the trend is steadily downward, and with yet others there is no trend at all. Such variations are difficult to explain solely on the basis of the maternal hyper¬ glycaemia theory, which other things being equal, might be expected to lead almost invariably to a progressive increase in the birth weight of the infants up to the point when diabetes is recognized and the maternal hyperglycaemia is controlled.
Growth hormone. Among other stimulants to foetal insulin production relevant to diabetes is the pituitary growth hormone, which can increase insulin production, acts as an insulin antagonist, can be diabetogenic, and could promote foetal beta cell hyper¬ plasia either directly or indirectly by causing hyperglycaemia. Although Hultquist & Engfeldt (1949) reported the development of oversized foetuses in experimental animals given growth hormone during pregnancy, this finding was not confirmed (Jost & Picon, 1957) , and it is now clear that excessive secretion of growth hormone cannot account for the unique morphology of the infant of the diabetic mother.
Since growth hormone does not pass the placenta (Gitlin et al. 19656 ), any effect of maternal growth hormone would have to be indirectly mediated-for example, through hyperglycaemia. The earlier bioassay methods for estimating growth hor¬ mone were too unreliable to give valid data (Ehrlich & Rändle, 1961 ; Chesley, 1963) , and the radioimmunoasay of growth hormone in pregnancy is complicated by interference from placental lactogen (Josimovich & McLaren, 1962) , which is biologic¬ ally and immunologically similar to but not identical with, the pituitary growth hormone (Greenwood, Hunter & Klopper, 1964) . Using the immunoassay, Laron and his colleagues (1967) Jackson, 1967) .
The excessive size of the infant of the diabetic mother is not due to abnormally high levels of foetal growth hormone since these babies have been shown to have significantly lower levels than normal infants (Cornblath et al. 1965; Laron et al. 1967) . This is in keeping with their low level of free fatty acids.
Synalbumin antagonist. Perhaps the most tempting hypothesis offered to fit the facts discussed above is the subject of much controversy at present. This is the hypothesis involving the synalbumin insulin antagonist described by Vallance Using specific methods to estimate the individual neutral steroids excreted in the urine of newborn infants, found greater adrenocortical activity in infants of diabetic mothers than in normal infants ; this was manifest by increased excretion of reducing corticosteroids of all ranges of polarity and could not be attributed merely to the fact that the infants of diabetic women were delivered prematurely according to standard clinical practice. The values for infants born to ' prediabetic ' women, i.e. women with treated gestational diabetes, were within the normal range, and there was no evidence of raised 17-hydroxycorticosteroid ex¬ cretion in the diabetic mothers. These workers showed also that the high corti¬ costeroid activity of infants of diabetic mothers increased still further with extraneous stress, e.g. in respiratory distress. Apart from quantitative differences, more subtle qualitative differences were also detected.
Aarskog (1963, 1965) High perinatal mortality It must be clearly understood that although the high perinatal mortality of the infants of diabetic mothers may be associated with inadequate metabolic homeostasis, mere size is not intimately related to mortality. Since excessive size and respiratory distress are both common among these babies as a group there has been a tendency to assume that these two features are closely linked. When foetal size is sufficient to obstruct vaginal delivery it may cause foetal death, and this, along with the observa¬ tion that control of maternal diabetes reduces both foetal birth weight and mortality (Pedersen, 1954; Wilkerson <fe Remein, 1957; Carrington, Shuman & Reardon, 1957; Hoet, Hoet & Gommers, 1959; Wilkerson, 1959; Carrington, 1960; Carrington & Messick, 1963) , has tended to support the hypothesis that the two are intimately related. It seems clear that this is not so and that in fact the incidence of still¬ birth, of the idiopathic respiratory distress syndrome and of neonatal death is sig¬ nificantly lower among large infants than among small ones (Farquhar, 1962) . Thus, the cause of disturbed function and of foetal death appears to be more than obesity and overgrowth resulting from an increased secretion of insulin.
The medical attendants of the pregnant diabetic women trying to secure the life of a usually very much wanted baby tread warily between the risk of sudden intra-uterine death, particularly after 36 weeks of gestation, on the one hand, and on the other, the danger of early neonatal death in premature infants who are peculiarly susceptible to the afflictions which beset all premature infants. These include respiratory distress with acidosis, hyperbilirubinaemia, hypoglycaemia, hypocalcaemia and abnormalities of salt and water metabolism (Farquhar, 1965a) . Study of the neonatal problems of the liveborn infants of diabetic mothers indicates that prematurity is the most important single factor influencing outcome. In 50%, the primary cause of death is respiratory distress (Hubbell & Drorbaugh, 1965 ; Pedersen & Pedersen, 1967 (Koller, 1953; Gellis & Hsia, 1959) (Farquhar, 1962) .
There is no doubt, however, that when maternal diabetes is well controlled, and there is no evidence of placental insufficiency, babies born after the 36th week have a better chance of survival.
However, it is still true that even good diabetic control maintained throughout pregnancy will not reduce the foetal loss rate to less than about 10 %. Farquhar (1962) has drawn attention also to the great variation in family patterns of mortality -the fact that some prediabetic and diabetic women can bear whole families of large babies who progress normally, while others lose several babies independent of the degree of control or the duration of clinical diabetes. He suggests that there may be an unrecognized factor independent of diabetic control which may be harmful to the foetus and which is more active in some women than in others. This may exert its effect upon the placenta (Burstein, Soule & Blumenthal, 1957) even in gestational diabetes (Aladjem, 1967) .
Congenital abnormalities
Pedersen and his colleagues (1964) have presented data from a carefully controlled study on a consecutive series of over 800 infants of diabetic mothers. In this series the incidence of multiple and lethal deformities was approximately six times greater than that in the general population. However, it should be noted that in other smaller, but carefully evaluated, series little evidence was found of this (Farquhar, 1959) . Horii and his colleagues (1966) have shown that treatment with insulin prevents the occurrence of an increased incidence of malformation in the foetuses of alloxandiabetic mice, which suggests that in these animals the teratogenic effect of diabetes in pregnancy is directly due to metabolic abnormalities in the foetal environment arising from the maternal diabetes. Rubin & Murphy (1958) found an increase in severe malformations in the offspring of female diabetics but not in the children of diabetic fathers, which would point to the same conclusion. However, other workers have shown that insulin itself can be teratogenic (Duraiswami, 1950; Wickes, 1954 )" perhaps when its administration causes severe hypoglycaemia early in pregnancy.
Using his synalbumin antagonist as a genetic marker for diabetes, Vallance-Owen and his colleagues (1967) (Fredrikson et al. 1967 ; Hagbard et al. 1969 ; Farquhar, 1959 ; Mestwerdt, 1967) and the incidence of diabetes mellitus in the early years is not unduly high. Harris (1950) has predicted that 1-4 % of children of a diabetic parent may be expected to develop clinical diabetes by the age of 40, but he found no evidence that the chances of diabetes developing were greater among the children of diabetic mothers compared with diabetic fathers. However, there is a need for long-term prospective follow-up studies of children (1) whose mothers had established diabetes before their birth, (2) of mothers who developed diabetes after they were born.
Attempts to study the problem by animal experiments have yielded contra¬ dictory results. Bartelheimer & Kloos (1952) have reported observations in the rat which showed that the offspring of animals treated with alloxan during pregnancy showed an abnormal rate of growth and prolonged growth and that this occurred in young animals of the second generation also. Some of these second-generation animals also showed transient hyperglycaemia and could be readily made diabetic by unusually small doses of alloxan. A similar study in the rabbit, with essentially similar findings, was reported by Okamoto (1964) . However, Gepts (1961) found no evidence of perma¬ nent damage to the foetal pancreas as a result of maternal diabetes induced by alloxan.
THE DIABETOGENIC EFFECT OF PREGNANCY ON THE MOTHER
Changes in glucose tolerance in normal pregnancy ; criteria of normality ; diagnosis of prediabetes Since Blot's report of glycosuria in pregnancy in 1856 there have been numerous conflicting studies of carbohydrate tolerance in pregnancy and the literature on this subject is very confusing. It is extremely difficult to compare results from studies which differed in the amount of glucose given and in its route of administration, and in the methods used to obtain blood samples and to estimate the blood sugar. Moreover, in many studies the stage of pregnancy at which carbohydrate tolerance was assessed is not stated and insufficient information is given about such factors as age, parity, weight and diet.
The numerous factors, many unrelated to carbohydrate metabolism, which may influence the oral glucose tolerance curve are well known (Baird & Duncan, 1959) . In pregnancy this method of assessing carbohydrate tolerance has the added dis¬ advantages that alterations in gastro-intestinal absorption (Hansen, 1937;  Williams, 1941; Hytten & Leitch, 1964) and renal function (Welsh & Sims, 1960) This conclusion has important implications. In the first place, caution is necessary in making a diagnosis of mild diabetes on the basis of a single test ; repeated testing may be necessary, particularly in pregnancy, where glucose tolerance may change during its course. Secondly, caution is necessary in evaluating the effects of treatment in border-line groups. Thirdly, in order to obtain valid information about the changes which occur in oral glucose tolerance in normal pregnancy, large groups of unselected subjects must be studied. Few published studies have paid attention to such matters and it is, therefore, difficult to say anything definite about changes in oral glucose tolerance in normal pregnancy and to define normal values.
However, although Jackson (1952) , giving 50 g. glucose, found that the mean oral glucose tolerance curve was lower in late pregnancy than in the normal non-pregnant state, there is much evidence that in normal pregnancy the blood glucose curve is often abnormally high if the classical criteria of normality for non-pregnant subjects are applied. This may be related to the glucose load, large loads revealing alterations in gastro-intestinal absorption. For example Hurwitz & Jensen (1946) , giving a glucose load of 1 g-/kg. body weight, concluded that carbohydrate tolerance decreased progressively throughout normal pregnancy, and they observed that because the blood glucose was so often higher than 120 mg./100 ml. 2 hr. after drinking the glucose solution, diabetes should only be diagnosed if the 3 hr. figure was above this level. Welsh (1960) , giving 100 g. glucose, reported 'abnormal' oral glucose tolerance curves in 50% of the 128 normal pregnancies he studied. Burt's (1954 Burt's ( , 1960 using cortisoneloaded glucose tolerance tests to identify potential diabetics in non-pregnant sub¬ jects and approximated to the prevalence of diabetes expected in the community (Wilkerson & Krall, 1947) . There are no comparable studies with the 50 g. oral test, but if Jackson is right then the criteria of normality for non-pregnant subjects should apply to pregnant women also (Strong & Baird, 1968) .
The intravenous glucose tolerance test overcomes many of the difficulties asso¬ ciated with the oral test and is highly reproducible (Duncan, 1956a ; Baird & Duncan, 1957) . Although the intravenous introduction of glucose into the body is less physio¬ logical than its absorption into the portal system, the observations of Samols indicate that the injection of 25 g. glucose intravenously provokes an insulin response in normal subjects which, other things being equal, determines glucose tolerance and reflects the capacity of the pancreatic islets to respond to the stimulus of hyperglycaemia, uncomplicated by other stimuli to insulin secretion which are involved when glucose is taken by mouth (Mclntyre, Holdsworth & Turner, 1964) . Moreover, these workers suggest that discrepancies between intravenous glucose tolerance and the insulin response may permit the precise assessment of resistance or sensitivity to endogenous insulin. (Picard, Ooms, Balasse & Conard, 1968) . Part of this can probably be accounted for by an increase in the distribution volume of glucose. However, the effects of increasing cell mass and blood fluid are minimal in the first trimester and progressively reach a maximum in later pregnancy. In contrast the change in intra¬ venous glucose tolerance proceeds in the opposite direction. It seems clear, therefore, that the two are not related. Nor can the changes be explained by an increased loss of glucose in the urine. In Silverstone's paper the mean urinary excretion of glucose within 1 hr. after an intravenous dose of 25 g. glucose was 0-9 g. or 3-6 % of the dose during pregnancy and 0-8 g. or 3-2% of the dose in the non-pregnant state. Other workers (Johnson & Bonsnes, 1948 ) report similar findings. There is no evidence for increased sensitivity to insulin in pregnancy-in fact, there is ample evidence of loss of insulin sensitivity particularly in late pregnancy (Burt, 1956; Burt, 1960a Jackson's (1964) finding, that 100 g. glucose orally produces an abnormal blood-glucose curve during normal pregnancy while 50 g. does not, may be relevant, and would fit in with our finding (Baird & Baird, 1965) (Jackson, 19616) , and this may be particularly so when cortisone rather than prednisolone is used. Mestman and his colleagues (1964) have suggested that there is potentiation of the biological effects of hydro cortisone during pregnancy, but not of those of prednisolone, as seems to occur in non-pregnant subjects receiving oestrogen (Nelson,, Tanney, Mestman, Gieschen & Wilson, 1963) , and that to duplicate the glucocorticoid effect of hydrocortisone, the ratio of potency of prednisolone to hydrocortisone in pregnancy may be 2:1 rather (Lunell, 1966) .
Although clinical diabetes is defined as 'a clinical syndrome characterized by hyperglycaemia due to a deficiency or a diminished effect of insulin' (Strong & Baird, 1968) (Quinto et al. 19676 ).
Plasma insulin in normal pregnancy
There is general agreement that the plasma insulin level is raised in pregnancy, whether it is measured by bioassay, using the rat epididymal fat pad (Welsh, 1960; Leake & Burt, 1962) or the rat diaphragm (Baird & Baird, 1965) ; or by immunoassay (Spellacy & Goetz, 19636 Beck & Kipnis, 1964; Trayner, Welborn, Rubenstein & Russell Fraser, 1966; Picard et al. 1968 ). The raised plasma insulin levels which appear to be characteristic of normal pregnancy would fit in with anatomical studies of the pancreas in pregnancy which have shown evidence of beta-cell hyperplasia (Rosenloecher, 1932) and a decrease of extractable pancreatic insulin along with beta-cell degranulation (Lopez-Quijada, Gomez-Acabo & Roderiquez-Candela, 1967) , with the resistance of pregnant animals to the diabetogenic action of growth hormone (Young, 1951) and alloxan (Miller, 1947) , and with the progressive decrease in the hypoglycaemic response to intravenous tolbutamide which occurs in normal pregnancy (Burt, 1958; Chesley, Kaufmann & Pauerstein, 1961) .
Among the possible explanations of the high level of circulating plasma insulin in pregnancy, four seem plausible. Excess insulin could be secreted as a compensatory phenomenon: (1) to counteract the effects of an increased amount of circulating insulin antagonist, for example, growth hormone, placental lactogen, thyroxine, adrenocorticosteroids or non-esterified fatty acids; (2) to overcome the decreased sensitivity of the peripheral tissues to insulin during pregnancy (Burt, 1958, I960«, 6; (3) to compensate for an increased rate of destruction of insulin by the placenta (Freinkel & Goodner, 1958; Buse et al. 1962; Freinkel, 1964) ; (4) excess insulin could also be secreted in response to a specific hormonal stimulus, i.e. oestrogen/progesterone from the placenta (Rodriquez, 1965; Spellacy, Gall & Carlson, 1967) .
It seems most likely that the alterations in carbohydrate metabolism which occur in pregnancy-that is, lowered blood glucose, raised plasma non-esterified fatty acids (Laron et al. 1967; Kalkhoff et al. 1964; Burt, 19606; Bleicher et al. 1964; Fairweather, 1965; Picard et al. 1968) , elevated plasma insulin, reduced sensitivity to insulin-are due to the effect of hormones produced by the placenta. Placental lactogen has a biological activity similar to growth hormone and could thus be responsible for the raised plasma non-esterified fatty acid and reduced insulin sensitivity, and indeed for the increased responsiveness of the pancreatic islets to an insulinogenic stimulus (Kalkhoff et al. 1964; Kalkhoff, Richardson, Beck & Stoddard, 1967) . Levels of placental lactogen are consistently detectable after 6 weeks of gestation, rising progressively to reach a plateau after 34 weeks (Beck, Parker <fe Daughaday, 1965; Samaan, Yen, Friesen & Pearson, 1966; Spellacy, Carlson & Birk, 1966; Saxena, Refetoff, Emerson & Selenkow, 1968) . Unlike growth hormone, the production of placental lactogen is unaffected by maternal exercise or ingestion of food. Beck, Parker <fe could find no significant difference between normal subjects, insulin-taking diabetics, and those with gestational diabetes treated with diet. However, Saxena et al. (1968) found that in five insulin-taking diabetics and one OHA-taking patient, the plasma placental lactogen levels rose to levels higher than normal after 28 weeks' gestation.
Oestrogen/progesterone could also be responsible for a rise in plasma insulin levels, either by a direct stimulating effect on the pancreas and/or due to increased synthesis and secretion of glucagon. The latter possibility is suggested by a study of the fine structure of the alpha cells of the pancreatic islets, which show definite signs of increased activity in pregnancy (Lopez-Quijada et al. 1967 ).
Fajans and Jackson (19616) have shown that the glucose tolerance curve of normal pregnant women is often abnormal if they have been primed with cortisone-in contrast to normal subjects who are not pregnant Duncan, 19566) . This would suggest that the triple load of pregnancy, glucose and cortisone may prove too much for even a normal pancreas.
In summary, therefore, it would appear that pregnancy is a functional burden on the beta cells of the pancreas and is, therefore, potentially diabetogenic. Whether it is of practical importance as a condition leading to the development of clinical diabetes in either normal or genetically susceptible individuals can be assessed by epidemiological studies of the parity of middle-aged diabetic women and non-diabetic subjects.
Glucose tolerance and plasma insulin in gestational diabetes Hoet (1954a) showed that pregnancy could potentiate a sub-liminal diabetogenic effect of cortisone or alloxan in rabbits, the combination causing hyperglycaemia which no one agent could produce on its own. Jackson in a number of publications (1961a) has fully documented the diabetogenic effect of pregnancy in the pre-or latent diabetic women when measured in terms of changes in carbohydrate tolerance during the course of pregnancy. Reports relating to levels of plasma insulin in these patients are conflicting. The majority (Welsh, 1960 ; Kalkhoff et al. 1964 ; Carrington & McWilliams, 1966; Trayner et al. 1966) consider that plasma insulin levels in subjects with gestational diabetes are higher than those in normal subjects; while De Gasparo and his colleagues (De Gasparo, Malherbe, Thomas & Hoet, 1967) consider that the levels are low and insulin response delayed. There is a need for further studies in similar groups of subjects.
Parity and the development of diabetes There is no evidence that the diabetogenic effect of pregnancy is permanent in the normal woman, since glucose tolerance does not decrease as parity rises (Lunell, 1966; Jackson, 1967) .
Reports that the incidence of diabetes is higher in married than in single women and that it rises with increasing parity support the suggestion that childbearing has a permanent diabetogenic effect in genetically susceptible subjects (Pyke, 1956; Fitzgerald, Malins, O'Sullivan & Wall, 1961) . However, others do not find these reports entirely convincing and feel that it is unlikely that parity alone can explain the well-documented preponderance of women with diabetes (Steinberg, 1958; Vinke, Wagelsmit, van Buchem & Smid, 1959; Jackson, 1961a) . More accurate data on the relationship of parity to the development of clinical diabetes have been derived from studies of diabetic sibships (Baird, et al. 1967) . Figure 1 shows that parity is inversely related to social class and that significant differences in parity between the three groups of siblings-diabetics, non-diabetic siblings of diabetics and non-diabetic siblings of non-diabetic subjects-are confined to obese women of high parity in social classes IV and V (unskilled occupations). In social classes I, II and III where the mean parity is less than three, there is no difference in parity between the groups; in social classes IV and V the low parity of the non-diabetic siblings of diabetic patients compared with that of the diabetic siblings and with that of the non-diabetic siblings of non-diabetic subjects, and the way in which the mean parity of this group falls in social classes IV and V below that of social classes I, II and III instead of rising at this point as the other two groups of siblings do, would suggest that this non-diabetic group has lost members of high parity to the diabetic group. Thus, the actual importance of pregnancy as a diabetogenic factor is mainly seen in obese individuals of parity 4 and over who have an inherited tendency to develop diabetes, and while it would appear that repeated childbearing can exert a specific diabetogenic effect, its influence in this respect will be limited in the absence of maternal obesity. Moreover, it is clear that in a modern, relatively prosperous community where the average parity is relatively low, the importance of pregnancy as a factor leading to the development of clinical diabetes will be relatively small. It is possible that the declining importance of this potentially diabetogenic factor could be associated with a genuine fall in the incidence of dia¬ betes in women and that this is partly the cause of the apparent change in the sex ratio for newly diagnosed cases of clinical diabetes in Britain (Malins, Fitzgerald & Wall, 1965) .
